Pitavastatin
Pitavastatin (usually as a calcium salt) is a member of the blood cholesterol lowering medication class of statins.
Like other statins, it is an inhibitor of HMG-CoA reductase, the enzyme that catalyses the first step of cholesterol synthesis.
It was patented in 1987 and approved for medical use in 2003. It is available in Japan, South Korea and in India. In the US, it received FDA approval in 2009.
Kowa Pharmaceuticals is the owner of the American patent to pitavastatin.
Q12140
medication
Concept
Q954845
statin
Concept
Q415607
HMG-CoA reductase
Concept
Q8047
enzyme
Concept
Q43656
cholesterol
Concept
Q884
South Korea
LOC
Q668
India
LOC
None
Kowa Pharmaceuticals
UNK
Q412677
Pitavastatin
Concept
1987-01-01T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
1987
DATE
2003-01-01T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
2003
DATE
2009-01-01T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
2009
DATE
instance of
subject has role
subclass of